0

Molecular Biology Enzymes, Kits, and Reagents Market by End-user and Geography - Forecast and Analysis 2021-2025

  • Published: Oct 2021
  • Pages: 120
  • SKU: IRTNTR71334
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The molecular biology enzymes, kits, and reagents market share is expected to increase by USD 13.09 billion from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 14.61%.

This molecular biology enzymes, kits, and reagents market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers molecular biology enzymes, kits, and reagents market segmentations by end-user (biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and academic institutes and research organizations) and geography (North America, Europe, Asia, and ROW). The molecular biology enzymes, kits, and reagents market report also offers information on several market vendors, including Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc.  , Takara Bio Inc., and Thermo Fisher Scientific Inc. among others.

What will the Molecular Biology Enzymes, Kits, and Reagents Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Molecular Biology Enzymes, Kits, and Reagents Market Size for the Forecast Period and Other Important Statistics

 

Molecular Biology Enzymes, Kits, and Reagents Market: Key Drivers, Trends, and Challenges

The increased use of proteins and reagents in biotechnology and pharmaceutical companies is notably driving the molecular biology enzymes, kits, and reagents market growth, although factors such as privacy issues concerning data leakage of genetic information may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the molecular biology enzymes, kits, and reagents industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Molecular Biology Enzymes, Kits, and Reagents Market Driver

Biotechnology and pharmaceutical companies are increasingly opting for molecular biology enzymes, kits, and reagents for various applications. For instance, Vivantis Technologies Sdn. Bhd., a research-based biotechnology company headquartered in Malaysia, has experience in recombinant enzyme production and novel chemistry for the creation of consumables necessary for molecular biology research, which increases the demand for proteins and reagents. Similarly, pharmaceutical companies are using proteins, enzymes, and reagents for the treatment of rare genetic disorders and diseases such as Gaucher's disease. Also, pharmaceutical companies are using glucose oxidase enzymes to detect the amount of glucose in the blood as an indicator for the diagnosis of diabetes. Thus, the increased use of proteins and reagents in biotechnology and pharmaceutical companies for applications such as drug discovery and development and in molecular biology research has propelled the growth of the global molecular biology enzymes, kits, and reagents market during the forecast period.

Key Molecular Biology Enzymes, Kits, and Reagents Market Trend

In recent years, end-users such as hospitals, diagnostic centers, academic institutes, and research organizations are increasingly opting for molecular biology kits that include enzymes and reagents for disease diagnosis. Molecular biology kits are highly used by end-users for the detection of molecular infectious diseases. These kits include primers, deoxyribonucleotide triphosphate (dNTPs), PCR buffers, and genomic DNA templates for monitoring PCR conditions and the comparison of the final amplified fragment. The advent of molecular technologies, coupled with the development of genomics, has significantly increased the use of molecular biology enzymes, kits, and reagents for the detection of pathogenic events at the genomic level. Such rising use of molecular biology kits for exploring disease-related genes and management of infectious diseases impacts the growth of the market positively. 

Key Molecular Biology Enzymes, Kits, and Reagents Market Challenge

The technological advances that are enabling researchers to easily sequence and interpret genomic information required for research and clinical uses increased the risk of data privacy of an individual's genetic information. As genetic information is stored in cloud databases for easy access to doctors and insurance companies, there is an increased privacy concern related to its use globally. Moreover, the blood and tissue samples collected in medical settings during biopsies can serve as sources of samples for genetic analysis, which increases the chances of data leakage. Also, the use of genomic testing for routine procedures in clinical settings increases the threat to patient privacy, as patients are potentially vulnerable to the misuse of their genetic information. Such privacy concerns led to the decreased popularity of DNA testing for obtaining genetic information and the creation of databases using molecular biology enzymes, kits, and reagents. 

This molecular biology enzymes, kits, and reagents market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

The growth in the global life sciences tools and services market will be driven by factors such as increasing life expectancy, expanding access to improved healthcare in emerging economies, and increasing prevalence of sedentary lifestyles. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the molecular biology enzymes, kits, and reagents market during the forecast period.

Who are the Major Molecular Biology Enzymes, Kits, and Reagents Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corp.
  • QIAGEN NV
  • Rockland Immunochemicals Inc.  
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

 

This statistical study of the molecular biology enzymes, kits, and reagents market encompasses successful business strategies deployed by the key vendors. The molecular biology enzymes, kits, and reagents market is fragmented and the vendors are deploying growth strategies such as product launches and business expansions to compete in the market.

Product Insights and News

  • Agilent Technologies Inc. - The company offers polymerase chain reaction (PCR) enzymes and reagents, inhibitors, and kits for various applications such as reverse transcriptase cloning, cDNA from an RNA template, and high-fidelity cloning.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The molecular biology enzymes, kits, and reagents market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Molecular Biology Enzymes, Kits, and Reagents Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the molecular biology enzymes, kits, and reagents market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of the life sciences tools and services market includes the following core components:

  • Research and development
  • Inputs
  • Production
  • Distribution
  • Marketing and sales
  • Post-sales and services
  • Industry innovations

The report has further elucidated on other innovative approaches being followed by vendors to ensure a sustainable market presence.

 

Which are the Key Regions for Molecular Biology Enzymes, Kits, and Reagents Market?

For more insights on the market share of various regions Request for a FREE sample now!

39% of the market’s growth will originate from North America during the forecast period. The US is a key market for molecular biology enzymes, kits, and reagents in North America. However, the market growth rate in this region will be slower than the growth of the market in Asia.

The presence of many vendors in the region will facilitate the molecular biology enzymes, kits, and reagents market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

In 2020, the outbreak of COVID-19 adversely affected all countries in North America, especially the US. The pandemic drove the regional molecular biology enzymes, kits, and reagents market owing to the increasing need for genomic testing and research activities to treat patients with COVID-19 in many North American countries, including the US, Canada, and Mexico. The emergence of the COVID-19 pandemic caused by SARS-CoV-2 compelled the scientific community in the region to understand all the aspects of this novel virus. As a result, the demand for new genomic products and services increased in the region in 2020. This positively impacted the market in 2020 and early 2021. Hence, the market is expected to grow steadily during the forecast period. 

What are the Revenue-generating End-user Segments in the Molecular Biology Enzymes, Kits, and Reagents Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The molecular biology enzymes, kits, and reagents market share growth by the biotechnology and pharmaceutical companies segment will be significant during the forecast period. The biotechnology and pharmaceutical companies that are primarily involved in the discovery and development of drugs to treat prevalent and new diseases are increasingly opting for molecular biology enzymes, kits, and reagents to identify drug targets. They are increasingly opting for molecular biology enzymes, kits, and reagents that are required to carry out molecular biotechnology research. Biotechnology companies such as Advanced Biotechnologies Inc. use molecular biology enzymes, kits, and reagents to offer virus growth, purification, inactivation, and quality control testing services to research laboratories, which boosts the growth of the market.

This report provides an accurate prediction of the contribution of all the segments to the growth of the molecular biology enzymes, kits, and reagents market size and actionable market insights on post COVID-19 impact on each segment.

 

Molecular Biology Enzymes, Kits, and Reagents Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 14.61%

Market growth 2021-2025

$ 13.09 billion

Market structure

Fragmented

YoY growth (%)

14.30

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 39%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agilent Technologies Inc., Bio Basic Inc., Bio Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Goldsite Diagnostics Inc., Hangzhou Matridx Biotechnology Co. Ltd., Illumina Inc., Jena Bioscience GmbH, LGC Ltd., Merck KGaA, New England Biolabs Inc., NZYTech Lda., Promega Corp., QIAGEN NV, Randox Laboratories Ltd., Rockland Immunochemicals Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., and Zymo Research Corp.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Molecular Biology Enzymes, Kits, and Reagents Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive molecular biology enzymes, kits, and reagents market growth during the next five years
  • Precise estimation of the molecular biology enzymes, kits, and reagents market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the molecular biology enzymes, kits, and reagents industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of molecular biology enzymes, kits, and reagents market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Biotechnology and pharmaceutical companies - Market size and forecast 2020-2025
  • Hospitals and diagnostic centers - Market size and forecast 2020-2025
  • Academic institutes and research organizations - Market size and forecast 2020-2025
  • Market opportunity by End-user

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Illumina Inc.
  • Merck KGaA
  • New England Biolabs Inc.
  • Promega Corp.
  • QIAGEN NV
  • Rockland Immunochemicals Inc.  
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The molecular biology enzymes, kits, and reagents market growth will increase by $13086.56 million during 2021-2025.
The molecular biology enzymes, kits, and reagents market is expected to grow at a CAGR of 14.61% during 2021-2025.
Technavio has segmented the molecular biology enzymes, kits, and reagents market by end user (Biotechnology and pharmaceutical companies, Hospitals and diagnostic centers, and Academic institutes and research organizations) and geographic (North America, Europe, Asia, and ROW).
Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc.  , Takara Bio Inc., Thermo Fisher Scientific Inc. are a few of the key vendors in the molecular biology enzymes, kits, and reagents market.
North America will register the highest growth rate of 38.80% among the other regions. Therefore, the molecular biology enzymes, kits, and reagents market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the molecular biology enzymes, kits, and reagents market growth are:
  • Increased use of proteins and reagents in biotechnology and pharmaceutical companies
The molecular biology enzymes, kits, and reagents market vendors should focus on grabbing business opportunities from the biotechnology and pharmaceutical companies segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>